This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations by Markus Wirges in Pharmaceutical Manufacturing
Introduction
Markus Wirges is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of pharmaceutical manufacturing, particularly in the development of dosage forms that enhance drug delivery.
Latest Patents
One of his key patents is titled "Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil." This invention focuses on manufacturing processes that prepare a pharmaceutical dosage form where nifedipine is released in a controlled manner, while candesartan cilexetil is released rapidly. The patent also allows for the optional inclusion of a diuretic that can be released immediately. This innovative approach aims to improve the therapeutic efficacy of the medications involved.
Career Highlights
Markus Wirges is associated with Bayer Pharma Aktiengesellschaft, a leading company in the pharmaceutical industry. His work at Bayer has allowed him to contribute to advancements in drug formulation and delivery systems.
Collaborations
Throughout his career, Markus has collaborated with esteemed colleagues such as Adrian Funke and Günter Meyer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Markus Wirges stands out as an inventor dedicated to improving pharmaceutical manufacturing processes. His innovative patent reflects his commitment to enhancing drug delivery systems, ultimately benefiting patients and the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile